Metabolic risks and effects of atypical antipsychotic treatment.

Dan W. Haupt, John M. Kane

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


Weight gain and the associated increased risk of diabetes and cardiovascular disease may be problems for individuals who receive long-term treatment with atypical antipsychotics. Atypical antipsychotics differ in their propensity to cause obesity and other metabolic disturbances. If a patient gains substantial weight while taking atypical antipsychotics, the physician should consider switching him or her to a drug with a lower risk of weight gain. The physician should also address patient lifestyle issues such as a poor diet and lack of exercise.

Original languageEnglish (US)
Pages (from-to)e24
JournalThe Journal of clinical psychiatry
Issue number10
StatePublished - Oct 2007

ASJC Scopus subject areas

  • Psychiatry and Mental health


Dive into the research topics of 'Metabolic risks and effects of atypical antipsychotic treatment.'. Together they form a unique fingerprint.

Cite this